Halma plc (LON:HLMA), the FTSE 100 global group of life-saving technology companies, has announced the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma’s Audit, Remuneration and Nomination Committees.
Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023.
His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc.
Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024.
Dame Louise Makin, Chair, commented:
“I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board.I would like to thank Roy for his valuable contribution to Halma, and particularly the support that he has given to me and the Board to ensure an orderly transition and onboarding of recent executive and non-executive Directors”
